Thursday, March 30, 2006

Pain Killer Fights Breast Cancer By Targeting Key Enzyme

WebWire, March 28, 2006
A pain–killing medication appears to halt the production of an enzyme that is key to a common form of breast cancer, a new study using tissue cultures suggests. The drug is called nimesulide. In laboratory experiments on breast cancer cells, scientists found that derivatives of nimesulide stopped the production of aromatase, the enzyme implicated in estrogen-dependent breast cancer. This form of breast cancer is the most common kind of breast cancer in postmenopausal women. Aromatase converts hormones called androgens into estrogens, such as the hormone estradiol. Estrogen is a powerful mitogen – an agent that causes cells to divide, and too much estrogen can cause cells to divide too quickly. --Click the title of this post to read the full article from its source--

0 Comments:

Post a Comment

<< Home

/* WebRing Code */